Ignite Creation Date:
2024-10-25 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06613659
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-21
Brief Title:
Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Cohort Study on the Efficacy of Traditional Chinese Medicine Syndrome Differentiation Scheme in Adjuvant Treatment of Severe Pneumonia Based on the Real World
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter prospective cohort study with syndrome differentiation and treatment of traditional Chinese medicine as the exposure factor Patients using syndrome differentiation of traditional Chinese medicine combined with conventional treatment of Western medicine are classified as the treatment cohort of Integrated Chinese and Western medicine and patients using conventional treatment of Western medicine only are classified as the treatment cohort of Western medicine
Detailed Description:
Severe pneumonia is a severe respiratory disease with high mortality many complications and poor prognosis Traditional Chinese medicine has certain curative effect in the adjuvant treatment of severe pneumonia but there is a lack of systematic TCM syndrome differentiation scheme and its curative effect evaluation in the real medical environment The cohort study on the efficacy of TCM syndrome differentiation scheme in the adjuvant treatment of severe pneumonia is conducive to providing new evidence for the optimization and evidence-based evaluation of TCM treatment scheme for severe pneumonia Therefore this study took severe pneumonia as the research object standardized use of traditional Chinese medicine diagnosis and treatment scheme as the exposure factor carried out a multi center prospective cohort study used the 90 day mortality 28 day mortality treatment failure rate etc to evaluate the clinical efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of severe pneumonia and provided evidence for the application and promotion of traditional Chinese medicine in severe pneumonia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None